Dickkopf-1 activates cell death in MDA-MB435 melanoma cells

Andrei M Mikheev1, Svetlana A Mikheeva, Robert Rostomily

  • 1Program in Cancer Biology, Divisions of Human Biology and Public Health, Fred Hutchinson Cancer Research Center, Seattle, WA 98104-2092, USA.

Insights

Activating Dickkopf-1 (DKK-1) in melanoma cells showed weak inhibition of tumor growth in mice. This suggests DKK-1 may promote apoptosis, making it incompatible with melanoma tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Dickkopf-1 (DKK-1) is a known inhibitor of the canonical Wnt pathway.
  • Recent studies suggest DKK-1 activation inhibits cell tumorigenicity.
  • Reduced DKK-1 levels are observed in melanomas.

Purpose of the Study:

  • To investigate if DKK-1 activation inhibits melanoma cell tumorigenicity.
  • To determine the effect of DKK-1 overexpression on melanoma growth in vivo.

Main Methods:

  • Overexpression of DKK-1 in the MDA-MB435 melanoma cell line.
  • Assessment of cell growth in soft agar.
  • Evaluation of tumorigenicity in nude mice.
  • Analysis of tumor necrosis and apoptosis using TUNEL assay.

Main Results:

  • DKK-1 overexpression did not affect cell growth in soft agar.
  • A weak but significant inhibition of tumorigenicity in nude mice was observed.
  • Tumors from DKK-1 overexpressing cells showed increased necrosis and apoptosis.

Conclusions:

  • DKK-1 activation in melanoma cells leads to apoptosis in vivo.
  • Increased apoptosis is incompatible with melanoma tumor growth in nude mice.
  • DKK-1 may represent a potential therapeutic target for melanoma.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...